相似化合物
116795-55-2 787502-41-4 1260890-44-5欧盟法规
C&L通报上下游产品
CAS号75-16-1 甲基溴化镁 | CAS号57090-88-7 1H-咪唑-4-甲腈 | CAS号100499-62-5 N-(5-methyl-1,2... | CAS号2466-76-4 1-乙酰基咪唑 | CAS号116795-55-2 1-(1-三苯甲基-1H-咪唑...N-(5-甲基-1,2-恶唑-4-基)甲酰胺置于palladium On Activated Charcoal Sodium Hydroxide,氢气体系中,用 乙醇 作为反应溶剂,化学反应 1.0H,反应生成 4-乙酰基咪唑
参考文献:Synthesis Of 4(5)-Acyl-,1-Substituted 5-Acyl-And 1-Substituted 4-Acyl-1H-Imidazoles From 4-Aminoisoxazoles
标题:Synthesis Of 4(5)-Acyl-,1-Substituted 5-Acyl-And 1-Substituted 4-Acyl-1H-Imidazoles From 4-Aminoisoxazoles
摘要:
DOI:10.1021/jo00389A015
专利信息
专利号:WO-2023230307-A1
优先权日:2022-05-27
标 题 :Methods for cobinamide synthesis
发明人:BOSS GERARD; CHAN ADRIANO
权利人:UNIV CALIFORNIA
摘要:Methods of synthesis of cobinamide compounds with improved yield and purity. Methods and compositions for treating cyanide, sulfide, sodium azide, or methane-thiol exposure in a subject.
专利号:US-7737287-B2
优先权日:2002-03-28
标 题 :Anomeric derivatives of monosaccharides
发明人:MEUTERMANS WIM; WEST MICHAEL LEO; GIANG THANH LE; ADAMSON GEORGE; SCHAFER KARL; ABBENANTE GIOVANNI
权利人:ALCHEMIA LTD
摘要:This invention relates to combinatorial libraries of potentially biologically active mainly monosaccharide compounds and to methods of preparing same. These compounds are variously functionalized, with a view to varying lipid solubility, size, function and other properties, with the particular aim of discovering a drug or drug-like compound, or compounds with useful properties. The invention provides intermediates, processes and synthetic strategies for the solution or solid phase synthesis of monosaccharides, variously functionalized about the sugar ring, including the addition of aromaticity and charge, and the placement of amino acid and peptide side chain units of isosteres thereof.
专利号:AU-2005243153-A1
优先权日:2004-05-07
标 题 :Scalable synthesis of imidazole derivatives
专利号:US-8178531-B2
优先权日:2010-02-23
标 题:Antiviral agents
发明人:OR YAT SUN; WANG GUOQIANG; GAO XURI
权利人:OR YAT SUN; WANG GUOQIANG; GAO XURI; ENANTA PHARM INC
摘要:The present invention relates to antiviral compounds of formula (I), n ncompositions containing these compounds, processes for their preparation, intermediates in their synthesis, and their use as therapeutics for prevention of organ transplantation rejection, the treatment of immune disorders and inflammation, and treatment of viral (particularly hepatitis C viral) infection.